Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dose Reduction and Discontinuation of Biologic and Targeted Synthetic disease‐modifying Anti‐rheumatic Drugs (DMARDs) in People With Axial Spondyloarthritis and Low Disease Activity." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438173/1/images/ios-appstore-badge.png. Accessed 03 May 2024.
Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438173/1/images/ios-appstore-badge.png. Accessed May 3, 2024.
Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438173/1/images/ios-appstore-badge.png
Dose Reduction and Discontinuation of Biologic and Targeted Synthetic disease‐modifying Anti‐rheumatic Drugs (DMARDs) in People With Axial Spondyloarthritis and Low Disease Activity [Internet]. In: Cochrane Abstracts. [cited 2024 May 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438173/1/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dose reduction and discontinuation of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity
ID - 438173
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438173/1/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -